Literature DB >> 7259914

Effects of chronic beta-blockade on intra-arterial blood pressure during motor car driving.

M W Millar-Craig, S Mann, V Balasubramanian, P Cashman, E B Raftery.   

Abstract

Continuous intra-arterial blood pressure recordings during motor car driving were performed in 15 patients with untreated essential hypertension, using the "Oxford" recording technique. Each subject was an experienced driver who used his car every day, and for the study drove from his work place to the hospital during the later afternoon. This drive took place in urban traffic and the average duration was 20.9 minutes. Blood pressure during car driving was remarkably stable, and the average systolic and diastolic pressures were similar to the mean daytime pressure. After 16 weeks of treatment with oxprenolol each patient was restudied. Blood pressure during driving had dropped from 176/107 to 160/93 mmHg, but the blood pressure response to driving and blood pressure variation during driving (expressed as the coefficient of variation) were unchanged. After treatment, the mean daytime systolic pressure was lower than the mean pressure during driving, but the relative antihypertensive effect during driving was similar to that observed in the same patients during dynamic exercise on a bicycle ergometer. No drug-induced side effects occurred and there were no apparent effects on driving ability. Chronic treatment with oxprenolol reduced blood pressure during car driving without affecting the normal blood pressure response to driving.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259914      PMCID: PMC482577          DOI: 10.1136/hrt.45.6.643

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Statistical analysis of the 24 hour blood pressure using pressure frequency histograms.

Authors:  M J West; P Sleight; A J Honour
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

2.  The value of ambulatory monitoring in borderline and established hypertension.

Authors:  J B Irving; H M Brash; F Kerr; B J Kirby
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

3.  The effect of mental arithmetic in normotensive and hypertensive subjects, and its modification by beta-adrenergic receptor blockade.

Authors:  G Nyberg; R M Graham; G S Stokes
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

4.  Some effects of motor-car driving on the normal and abnormal heart.

Authors:  P Taggart; D Gibbons; W Somerville
Journal:  Br Med J       Date:  1969-10-18

5.  New system for recording ambulatory blood pressure in man.

Authors:  M W Millar-Craig; D Hawes; J Whittington
Journal:  Med Biol Eng Comput       Date:  1978-11       Impact factor: 2.602

6.  Hybrid system for fast data reduction of long-term blood-pressure recordings.

Authors:  P M Cashman; F D Stott; M W Craig
Journal:  Med Biol Eng Comput       Date:  1979-09       Impact factor: 2.602

7.  Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.

Authors:  R D Watson; T J Stallard; W A Littler
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

8.  Direct arterial pressure and electrocardiogram during motor car driving.

Authors:  W A Littler; A J Honour; P Sleight
Journal:  Br Med J       Date:  1973-05-05

9.  Use of graded exercise testing in assessing the hypertensive patient.

Authors:  M W Millar-Craig; V Balasubramanian; S Mann; E B Raftery
Journal:  Clin Cardiol       Date:  1980-08       Impact factor: 2.882

10.  Effects of chronic renal insufficiency and metabolic acidosis on glutamine metabolism in man.

Authors:  A Tizianello; G De Ferrari; G Garibotto; G Gurreri
Journal:  Clin Sci Mol Med       Date:  1978-10
View more
  1 in total

1.  Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.

Authors:  K Eliasson; T Kahan; B Hylander; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.